Stage IIA Skin Melanoma Treatment With ECHO-7 Oncolytic Virus Rigvir

Perm J. 2022 Sep 14;26(3):139-144. doi: 10.7812/TPP/21.232. Epub 2022 Aug 11.

Abstract

Melanoma is a global problem due to the rising numbers of skin melanoma cases. Current treatment guidelines for patients with stage IIA melanoma recommend only observation after surgery. In this report, the authors describe a patient with stage IIA skin melanoma treated with surgery and Rigvir virotherapy. Two years after the patient discovered a brown spot on the right cheek, surgery was indicated because the mass had started to ulcerate. Rigvir virotherapy was applied both before and after surgery. Observations made more than 7 years after surgery indicated no signs of disease progression. This case report illustrates an early treatment approach. Neoadjuvant treatment for early-stage melanoma is gaining more interest in both scientific and medical communities; therefore, the authors believe it is relevant to share their observations.

Keywords: ECHO-7 virus; Rigvir; case report; melanoma; oncolytic virus; peritumoral administration; virotherapy.

Publication types

  • Case Reports

MeSH terms

  • Enterovirus B, Human
  • Humans
  • Melanoma* / therapy
  • Melanoma, Cutaneous Malignant
  • Oncolytic Viruses*
  • Skin Neoplasms* / therapy